GFAP alternative splicing regulates glioma cell–ECM interaction in a DUSP4-dependent manner
van Bodegraven, Emma J.; van Asperen, Jessy V.; Sluijs, Jacqueline A.; van Deursen, Coen B.J.; van Strien, Miriam E.; Stassen, Oscar M.J.A.; Robe, Pierre A.J.; Hol, Elly M.
(2019) FASEB Journal, volume 33, issue 11, pp. 12941 - 12959
(Article)
Abstract
Gliomas are the most common primary brain tumors. Their highly invasive character and the heterogeneity of active oncogenic pathways within single tumors complicate the development of curative therapies and cause poor patient prognosis. Glioma cells express the intermediate filament protein glial fibrillary acidic protein (GFAP), and the level of its
... read more
alternative splice variant GFAP-δ, relative to its canonical splice variant GFAP-α, is higher in grade IV compared with lower-grade and lower malignant glioma. In this study we show that a high GFAP-δ/α ratio induces the expression of the dual-specificity phosphatase 4 (DUSP4) in focal adhesions. By focusing on pathways up- and downstream of DUSP4 that are involved in the cell-extracellular matrix interaction, we show that a high GFAP-δ/α ratio equips glioma cells to better invade the brain. This study supports the hypothesis that glioma cells with a high GFAP-δ/α ratio are highly invasive and more malignant cells, thus making GFAP alternative splicing a potential therapeutic target.—Van Bodegraven, E. J., van Asperen, J. V., Sluijs, J. A., van Deursen, C. B. J., van Strien, M. E., Stassen, O. M. J. A., Robe, P. A. J., Hol, E. M. GFAP alternative splicing regulates glioma cell–ECM interaction in a DUSP4-dependent manner. FASEB J. 33, 12941–12959 (2019). www.fasebj.org.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: cytoskeleton, extracellular matrix, GFAP isoforms, glioblastoma multiforme, intermediate filaments, Biotechnology, Biochemistry, Molecular Biology, Genetics
ISSN: 0892-6638
Publisher: John Wiley & Sons Inc.
Note: Funding Information: The results shown here are in part based upon data generated by the The Cancer Genome Atlas (TCGA) Research Network ( http://cancergenome.nih.gov/ ). This work was supported by the research program of the Foundation for Fundamental Research on Matter (FOM; Grant 09MMC06), the Netherlands Organization for Scientific Research (NWO; VICI Grant 865.09.003), the T. and P. Bohnenn Foundation, and the Dutch Cancer Society [KWF 10123]. P.A.J.R. and E.M.H. share senior authorship. The authors declare no conflicts of interest. Funding Information: The results shown here are in part based upon data generated by the The Cancer Genome Atlas (TCGA) Research Network (http://cancergenome.nih.gov/). This work was supported by the research program of the Foundation for Fundamental Research on Matter (FOM; Grant 09MMC06), the Netherlands Organization for Scientific Research (NWO; VICI Grant 865.09.003), the T. and P. Bohnenn Foundation, and the Dutch Cancer Society [KWF 10123]. P.A.J.R. and E.M.H. share senior authorship. The authors declare no conflicts of interest. Publisher Copyright: © FASEB
(Peer reviewed)